You are here

Rob Davis

Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts

BioPharma Dive

Fri, 02/9/24 - 11:26 am

Bristol Myers Squibb

PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US

Fierce Pharma

Thu, 02/8/24 - 10:08 pm

Bristol Myers Squibb

Merck still in the market for deals in the $1B to $15B range, CEO says

Fierce Pharma

Thu, 02/1/24 - 10:56 pm

Prometheus Biosciences

Merck seeks GLP-1 drugs with benefits beyond weight loss - CEO

Reuters

Fri, 01/5/24 - 11:28 am

Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'

Endpoints

Fri, 10/28/22 - 10:22 am

'We need to do more': Merck CEO Rob Davis highlights M&A, deals strategy ahead of '28 Keytruda patent cliff

Endpoints

Fri, 02/4/22 - 11:13 am

Merck’s Davis Looking to Diversify in Preparation for Keytruda Patent Cliff

BioSpace

Wed, 10/6/21 - 11:23 pm